Subject(s)
American Heart Association , Atrial Fibrillation/therapy , Cardiology/standards , Practice Guidelines as Topic/standards , Societies, Medical/standards , Thoracic Surgical Procedures/standards , Advisory Committees/standards , Atrial Fibrillation/epidemiology , Atrial Fibrillation/physiopathology , Disease Management , Heart Rate/physiology , Humans , Research Report/standards , United States/epidemiologySubject(s)
Tachycardia, Supraventricular/therapy , Adolescent , Adult , Cardiovascular Agents/economics , Cardiovascular Agents/therapeutic use , Catheter Ablation/economics , Child , Child, Preschool , Combined Modality Therapy , Cost-Benefit Analysis , Decision Making , Diagnostic Techniques, Cardiovascular , Disease Management , Electrocardiography , Evidence-Based Medicine , Female , Humans , Male , Pregnancy , Pregnancy Complications, Cardiovascular/therapy , Quality of Life , Tachycardia, Supraventricular/classification , Tachycardia, Supraventricular/diagnosis , Tachycardia, Supraventricular/economics , Tachycardia, Supraventricular/epidemiology , Tachycardia, Supraventricular/physiopathology , Young AdultSubject(s)
Tachycardia, Supraventricular/therapy , Adolescent , Adult , Cardiovascular Agents/economics , Cardiovascular Agents/therapeutic use , Catheter Ablation/economics , Child , Child, Preschool , Combined Modality Therapy , Cost-Benefit Analysis , Decision Making , Diagnostic Techniques, Cardiovascular , Disease Management , Electrocardiography , Evidence-Based Medicine , Female , Humans , Male , Pregnancy , Pregnancy Complications, Cardiovascular/therapy , Quality of Life , Tachycardia, Supraventricular/classification , Tachycardia, Supraventricular/diagnosis , Tachycardia, Supraventricular/economics , Tachycardia, Supraventricular/epidemiology , Tachycardia, Supraventricular/physiopathology , Young AdultSubject(s)
Myocardial Infarction/therapy , Percutaneous Coronary Intervention , Electrocardiography , Evidence-Based Medicine , Humans , Myocardial Infarction/physiopathology , Myocardial Infarction/surgery , Percutaneous Coronary Intervention/methods , Randomized Controlled Trials as Topic , Thrombectomy/methods , Treatment OutcomeABSTRACT
Coronary artery disease is a leading cause of death worldwide. There has been a myriad of advancements in the field of cardiovascular imaging to aid in diagnosis, treatment, and prevention of coronary artery disease. The application of artificial intelligence in medicine, particularly in cardiovascular medicine has erupted in the past decade. This article serves to highlight the highest yield articles within cardiovascular imaging with an emphasis on coronary CT angiography methods for % stenosis evaluation and atherosclerosis quantification for the general cardiologist. The paper finally discusses the evolving paradigm of implementation of artificial intelligence in real world practice.
ABSTRACT
COVID-19 has been associated with significant risk for cardiac arrhythmias, particularly in patients with underlying cardiac conditions or prior histories of arrhythmia. It has been shown that a Brugada pattern can be unmasked in febrile patients with COVID-19. Herein we report a unique case of an afebrile patient without known prior history of Brugada presenting with Brugada pattern on ECG.
Subject(s)
Brugada Syndrome , COVID-19 , Arrhythmias, Cardiac , Brugada Syndrome/complications , Brugada Syndrome/diagnosis , Electrocardiography , Humans , SARS-CoV-2ABSTRACT
This report documents a rare case of COVID-19-associated constrictive pericarditis (CP) in the setting of a recent COVID-19 infection. A 55-year-old man with a history of hypertension and gout presented with acute hypoxic respiratory failure and was diagnosed with COVID-19 pneumonia with progression to acute respiratory distress syndrome. His hospital course was complicated by a large pericardial effusion; an emergent bedside transthoracic echocardiography was concerning for cardiac tamponade, so pericardiocentesis was performed. A workup with cardiac magnetic resonance imaging showed changes consistent with a diagnosis of CP. Viral and idiopathic aetiologies are the most common cause of CP in the developed world, with COVID-19 now a proposed predisposing viral illness. The virus induces systemic inflammation and pericardial changes that can lead to CP physiology. Imaging modalities including echocardiogram and cardiac magnetic resonance play an integral role in confirming the diagnosis.
Subject(s)
COVID-19 , Cardiac Tamponade , Pericardial Effusion , Pericarditis, Constrictive , Pericarditis , Cardiac Tamponade/diagnostic imaging , Cardiac Tamponade/etiology , Humans , Male , Middle Aged , Pericardial Effusion/surgery , Pericardiocentesis , Pericarditis, Constrictive/diagnostic imaging , Pericarditis, Constrictive/etiology , SARS-CoV-2Subject(s)
Myocardial Infarction/therapy , Myocardial Reperfusion/methods , Percutaneous Coronary Intervention , Risk Assessment , Thrombolytic Therapy , American Heart Association , Cardiology/methods , Cardiology/standards , Diagnostic Techniques, Cardiovascular , Disease Management , Electrocardiography , Emergency Medical Services/methods , Emergency Medical Services/organization & administration , Evidence-Based Medicine/methods , Evidence-Based Medicine/standards , Humans , Medication Therapy Management/standards , Myocardial Infarction/diagnosis , Myocardial Infarction/epidemiology , Patient Selection , United StatesSubject(s)
Advisory Committees/standards , American Heart Association , Atrial Fibrillation/therapy , Cardiology/standards , Practice Guidelines as Topic/standards , Research Report/standards , Advisory Committees/trends , Atrial Fibrillation/diagnosis , Atrial Fibrillation/epidemiology , Disease Management , Humans , Research Report/trends , United States/epidemiologySubject(s)
Myocardial Infarction/therapy , Myocardial Reperfusion/methods , Percutaneous Coronary Intervention , Risk Assessment , Thrombolytic Therapy , American Heart Association , Cardiology/methods , Cardiology/standards , Clinical Protocols/classification , Clinical Protocols/standards , Diagnostic Techniques, Cardiovascular , Disease Management , Electrocardiography , Emergency Medical Services/methods , Emergency Medical Services/organization & administration , Evidence-Based Medicine/methods , Evidence-Based Medicine/standards , Humans , Medication Therapy Management/standards , Myocardial Infarction/diagnosis , Myocardial Infarction/epidemiology , Patient Selection , United StatesABSTRACT
Transcatheter aortic valve implantation (TAVI) is an acceptable treatment for severe aortic stenosis in high or intermediate risk patients. Conduction abnormalities are a known complication of TAVI. Most abnormalities occur perioperatively but can develop later. The predictors of delayed conduction abnormalities are unknown. Patients who underwent TAVI at our institution were reviewed. Patients with a pre-existing pacemaker were excluded. Baseline, in-hospital, and 30-day follow-up ECGs were reviewed. Patient and procedural characteristics were analyzed to look for predictors of acute and delayed abnormalities. Ninety-eight patients were included. All valves implanted were balloon expandable, most commonly SAPIEN S3 (78%). Thirty-seven (37.7%) patients developed abnormalities before discharge. Of these patients, 20 (57.1%) had complete resolution at 30-day follow-up. No patients with new conduction abnormalities during hospitalization had additional abnormalities at 30-day follow-up. Five (5.1%) patients developed new conduction abnormalities following discharge. Overall, 22 (22.4%) patients had conduction abnormalities at 30-day follow-up which were not present at baseline. Predilatation (pâ¯=â¯0.003), higher ratios of balloon (pâ¯=â¯0.03) or valve (pâ¯=â¯0.05) size to left ventricular outflow tract, and previous myocardial infarction (pâ¯=â¯0.034) were predictive of acute conduction abnormalities. Baseline right bundle branch block (pâ¯=â¯0.002), longer baseline (p <0.001) and discharge (pâ¯=â¯0.004) QRS duration, moderate, or severe aortic insufficiency (pâ¯=â¯0.002) and atrial fibrillation (pâ¯=â¯0.031) were predictors of new conduction abnormalities after discharge. In conclusion, most new in-hospital conduction abnormalities resolve by 30-day follow-up. In-hospital conduction abnormalities are related to technical aspects of TAVI while delayed conduction abnormalities are related to baseline conduction system disease.
Subject(s)
Aortic Valve Stenosis/surgery , Cardiac Conduction System Disease/etiology , Heart Valve Prosthesis , Postoperative Complications/etiology , Transcatheter Aortic Valve Replacement/adverse effects , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Prognosis , Prosthesis Design , Retrospective Studies , Time Factors , Treatment OutcomeSubject(s)
Cardiology/standards , Coronary Artery Bypass/standards , Myocardial Infarction/therapy , Percutaneous Coronary Intervention/standards , Thrombolytic Therapy/standards , Anticoagulants/therapeutic use , Coronary Angiography/standards , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass/mortality , Humans , Myocardial Infarction/diagnosis , Myocardial Infarction/mortality , Percutaneous Coronary Intervention/adverse effects , Percutaneous Coronary Intervention/instrumentation , Percutaneous Coronary Intervention/mortality , Platelet Aggregation Inhibitors/therapeutic use , Predictive Value of Tests , Risk Assessment , Risk Factors , Stents/standards , Thrombolytic Therapy/adverse effects , Thrombolytic Therapy/mortality , Time-to-Treatment/standards , Treatment OutcomeABSTRACT
Little is known about how patient and primary care physician characteristics are associated with quality of depression care. The authors conducted structured interviews of 404 randomly selected primary care physicians after their interaction with CD-ROM vignettes of actors portraying depressed patients. Vignettes varied along the dimensions of medical comorbidity, attributions regarding the cause of depression, style, race/ethnicity, and gender. Results show that physicians showed wide variation in treatment decisions; for example, most did not inquire about suicidal ideation, and most did not state that they would inform the patient that there can be a delay before an antidepressant is therapeutic. Several physician characteristics were significantly associated with management decisions. Notably, physician age was inversely correlated with a number of quality-of-care measures. In conclusion, quality of care varies among primary care physicians and appears to be associated with physician characteristics to a greater extent than patient characteristics.